Patient Perspectives on Virtual Care for Diabetes Management in the Era of COVID-19

The aim of this study was to characterize patient perspectives on the quality of diabetes care at The Ottawa Hospital Endocrinology and Metabolism multidisciplinary clinic delivered virtually during the COVID-19 pandemic. An online survey was developed to collect quantitative and qualitative data on patients’ experiences with virtual diabetes clinic visit between March 2020 and April 2021. A total of 333 patients were included in this study; 45% were female and had a mean age of 60 years. Seventy-nine percent were born in Canada and 87% identified as Caucasian. Thirty-six percent were treated for type 1 diabetes and 62% for type 2 diabetes. Eighty-seven percent of virtual visits occurred by phone, with 12% of these on Zoom. Overall, 83% were “very satisfied” or “satisfied” with their virtual care experience. Most respondents perceived all treatment-related factors to be equally well addressed virtually as in person, except for physical examination. Auxiliary factors like travel, cost, and time spent were rated more favourably with virtual care. Qualitative findings provided further contextualization and identified gaps in virtual care delivery. For future visits, 44% wanted in-person visits only as needed, 36% wanted a hybrid of in-person and virtual appointments, and 11% preferred in-person appointments only. Patients perceive that virtual care provides high-fidelity diabetes management while reducing their pandemic risks as well as minimizing travel and time associated with in-person care. Virtual care is an important medium for diabetes care delivery that should be used according to patient preference and intermixed with in-person appointments. La présente étude visait à connaître les points de vue des patients sur la qualité des soins virtuels offerts aux personnes diabétiques de la clinique multidisciplinaire d’endocrinologie et de métabolisme de l’Hôpital d’Ottawa durant la pandémie de COVID-19. Une enquête en ligne a été conçue pour collecter les données quantitatives et qualitatives sur les expériences des patients qui avaient eu des consultations cliniques virtuelles entre mars 2020 et avril 2021. Cette étude regroupait un total de 333 patients, dont 45 % étaient des femmes et dont l’âge moyen était de 60 ans. Soixante-dix-neuf pour cent (79 %) étaient nés au Canada, et 87 % se disaient de race blanche. Trente-six pour cent (36 %) étaient traités en raison du diabète de type 1, et 62 %, en raison du diabète de type 2. Quatre-vingt-sept pour cent (